Irina M. Khidiyatova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Irina M. Khidiyatova has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- E. K. Khusnutdinova
Bashkir State Medical University, Ufa, Russia
7 shared publications - Aleksandra S. Karunas
Institute of Biochemistry and Genetics–Subdivision of the Ufa Federal Research Centre of the Russian Academy of Sciences (IBG UFRC RAS), 450054 Ufa, Russia
4 shared publications E. K. Khusnutdinova
Institute of Biochemistry and Genetics—Subdivision of the Ufa Federal Research Centre, Russian Academy of Sciences, Ufa, Russia
4 shared publications- Irina R. Gilyazova
Institute of Biochemistry and Genetics, Ufa Federal Research Center of the Russian Academy of Sciences; Bashkir State Medical University
4 shared publications R. V. Magzhanov
Bashkir State Medical University, Ufa, Russia
4 shared publications- Rim V. Magzhanov
Bashkir State Medical University
4 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 3,p. 32-36
Genetic variability of rs10774671 of the OAS1 gene associated with antiviral protection in subpopulations of Bashkirs and Tatars of the Volga-Ural region
Today, infectious diseases occupy a leading position among other diseases causing concerns among the population, leading to a decrease in work capacity and a number of serious complications. Monitoring infectious diseases and preparing for future outbreaks is crucial for the development of genetic epidemiology and public health in general. In this study, we analyzed the allele and genotype frequency distribution of the rs10774671 (G>A) variant of the OAS1 gene, previously associated with infectious diseases, in subpopulations of Bashkirs and Tatars living in the Volga-Ural region. We paid special attention to the study of subpopulations to obtain the most accurate results of the frequency distribution of this locus in such large populations as Bashkirs and Tatars. A study of the allele and genotype distribution of the rs10774671 genetic variant of the OAS1 gene was conducted using PCR followed by RFLP analysis. A pairwise comparison of allele frequencies between the studied populations revealed statistically significant differences between the Permsky Bashkirs subpopulation and the Askinsky, Burzyansky and Orenburgsky Bashkirs subpopulations (p<0.05). The Ewens-Watterson test for the total Bashkirs sample, including all the studied subpopulations, demonstrated the presence of balancing selection (Fo=0.5405, Fe=0.6461, p<0.05). A separate analysis of each subpopulation revealed the effect of balancing selection on the Orenburgsky Bashkirs (Fo=0.4375, Fe=0.5957, p<0.05). These results will add to our knowledge of the distribution of the rs10774671 genetic variant of the OAS1 gene in populations worldwide.
- 15 October 2026
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 3,p. 32-36
Open AccessGenetic variability of rs10774671 of the OAS1 gene associated with antiviral protection in subpopulations of Bashkirs and Tatars of the Volga-Ural region
Today, infectious diseases occupy a leading position among other diseases causing concerns among the population, leading to a decrease in work capacity and a number of serious complications. Monitoring infectious diseases and preparing for future outbreaks is crucial for the development of genetic epidemiology and public health in general. In this study, we analyzed the allele and genotype frequency distribution of the rs10774671 (G>A) variant of the OAS1 gene, previously associated with infectious diseases, in subpopulations of Bashkirs and Tatars living in the Volga-Ural region. We paid special attention to the study of subpopulations to obtain the most accurate results of the frequency distribution of this locus in such large populations as Bashkirs and Tatars. A study of the allele and genotype distribution of the rs10774671 genetic variant of the OAS1 gene was conducted using PCR followed by RFLP analysis. A pairwise comparison of allele frequencies between the studied populations revealed statistically significant differences between the Permsky Bashkirs subpopulation and the Askinsky, Burzyansky and Orenburgsky Bashkirs subpopulations (p<0.05). The Ewens-Watterson test for the total Bashkirs sample, including all the studied subpopulations, demonstrated the presence of balancing selection (Fo=0.5405, Fe=0.6461, p<0.05). A separate analysis of each subpopulation revealed the effect of balancing selection on the Orenburgsky Bashkirs (Fo=0.4375, Fe=0.5957, p<0.05). These results will add to our knowledge of the distribution of the rs10774671 genetic variant of the OAS1 gene in populations worldwide.
- 5 October 2026
- Published by Pleiades Publishing Ltd in Russian Journal of Genetics
- Vol. 62 (10) , 1235-1249
The Role of Biobanks of Genetic Material as a Way to Conserve Breed Diversity of Farm Birds
Intensive selection and inbreeding in farm bird populations (Gallus gallus domesticus) lead to reduced genetic diversity, a decrease in effective population size, and the loss of rare alleles. Biobanks of genetic resources serve as repositories for gene pool conservation, ensuring the recording of allele frequencies, haplotype profiles, and population structure. This review presents a comprehensive analysis of the status and prospects for biobanking of farm bird genetic resources as a strategic tool for preserving biodiversity and accelerating breeding progress. The review discusses the types of biobanks and the biological material they preserve, describes the features of cryopreservation in birds, examines key international and domestic centers and global initiatives for the conservation of animal genetic material, and provides an interdisciplinary analysis of biobanking of avian genetic resources in the context of epidemiological safety, regulatory frameworks, and technological development prospects. Particular attention is paid to Russian collections of chicken biological material with verified phenotypes as well as integration with international FAO/ERFP/EUGENA standards within the framework of the “One Health/One Biodiversity” concept.
- 5 October 2026
- Published by Pleiades Publishing Ltd in Russian Journal of Genetics
- Vol. 62 (10) , 1235-1249
The Role of Biobanks of Genetic Material as a Way to Conserve Breed Diversity of Farm Birds
Intensive selection and inbreeding in farm bird populations (Gallus gallus domesticus) lead to reduced genetic diversity, a decrease in effective population size, and the loss of rare alleles. Biobanks of genetic resources serve as repositories for gene pool conservation, ensuring the recording of allele frequencies, haplotype profiles, and population structure. This review presents a comprehensive analysis of the status and prospects for biobanking of farm bird genetic resources as a strategic tool for preserving biodiversity and accelerating breeding progress. The review discusses the types of biobanks and the biological material they preserve, describes the features of cryopreservation in birds, examines key international and domestic centers and global initiatives for the conservation of animal genetic material, and provides an interdisciplinary analysis of biobanking of avian genetic resources in the context of epidemiological safety, regulatory frameworks, and technological development prospects. Particular attention is paid to Russian collections of chicken biological material with verified phenotypes as well as integration with international FAO/ERFP/EUGENA standards within the framework of the “One Health/One Biodiversity” concept.
- Open Access
- 20 September 2026
- Published by Moscow Regional Research and Clinical Institute (MONIKI) in Almanac of Clinical Medicine
- Vol. 54 (3) , 113-125
Ethnic variability of pharmacogenetic TPMT and NUDT15 variants in Russian populations: Implications for personalized thiopurine therapy
Background: Thiopurines, including azathioprine and 6-mercaptopurine, are widely used in the treatment of inflammatory and autoimmune diseases, as well as hematological malignancies; however, their use is limited by the risk of severe myelosuppression. Pharmacogenetic variants in the TPMT and NUDT15 genes significantly affect drug tolerability, and their frequencies vary markedly across ethnic groups, making population-based studies of these markers in different regions of Russia particularly important. Aim: To assess interethnic variability in the frequencies of clinically relevant TPMT rs1142345 and NUDT15 rs116855232 polymorphisms in populations of the Volga-Ural region, North Caucasus, and the Lower Volga region. Methods: Data from 1687 healthy males from 27 populations and 15 ethnogeographic groups (Bashkirs, Tatars, Mordvins, Chuvash, Mari, Udmurts, Komi, Besermyans, Kalmyks, Balkars, Karachays, Circassians, Ingush, Chechens, and Moldovans), collected during field expeditions in 2000–2025, were retrospectively analyzed. Information on date and place of birth, family history of disease, ethnicity of parents and grandparents (maternal and paternal lines), and causes of death of closed relatives was collected by questionnaire. Individuals with mixed ancestry were excluded. Genomic DNA was extracted from venous blood; genotyping of TPMT rs1142345 and NUDT15 rs116855232 was performed by real-time polymerase chain reaction with TaqMan probes. Results: The minor allele rs1142345*C of TPMT (TPMT*3C) was rare or absent in most of the studied groups, with the highest frequencies observed in Chuvash (3.65%), Circassians (3.23%), and Mordvins (3.16%). The minor allele rs116855232*T of NUDT15 (NUDT15*3) was more frequent in Kalmyks (15.6%), Bashkirs from Perm Krai (14.77%), and Bashkirs of the Samara and Saratov Regions (14.63%), whereas it was absent in Moldovans and occurred at minimal frequencies in Mordvins (0.52%), Chechens (1.03%) and Ingush (1.61%). The most significant differences in NUDT15*3 allele frequency were observed between Kalmyks and Mordvins (15.60% vs 0.52%; p = 2.7 × 10-9, p_FDR = 9.3 × 10-7), Kalmyks and Chechens (15.60% vs 1.03%; p = 2.4 × 10-8, p_FDR = 3.8 × 10-6), and Kalmyks and Moldovans (15.60% vs 0.0%; p = 3.2 × 10-8, p_FDR = 3.8 × 10-6). Among the Bashkir subgroups, the greatest differences were found between Bashkirs from Perm Krai and Mordvins (14.77% vs 0.52%; p = 1.4 × 10-6, p_FDR = 1.3 × 10-4), between Bashkirs from Samara and Saratov Regions and Mordvins (14.63% vs 0.52%; p = 2.5 × 10-6, p_FDR = 1.8 × 10-4), and between Bashkirs from Perm Krai and Moldovans (14.77% vs 0.0%; p = 3.4 × 10-6, p_FDR = 2.0 × 10-4) and Chechens (14.77% vs 1.03%; p = 8.0 × 10-6, p_FDR = 3.5 × 10-4). Conclusion: The results confirm substantial ethnic heterogeneity in the distribution of pharmacogenetic markers of thiopurine toxicity. The minor allele rs116855232*T of NUDT15 was significantly more prevalent in the studied populations than the minor allele rs1142345*C of TPMT, and its frequencies in several groups were comparable to those in East Asian populations. This supports the utility of genotyping for personalizing azathioprine therapy in Russian regions.
- 20 September 2026
- Published by Moscow Regional Research and Clinical Institute (MONIKI) in Almanac of Clinical Medicine
- Vol. 54 (3) , 113-125
Open AccessEthnic variability of pharmacogenetic TPMT and NUDT15 variants in Russian populations: Implications for personalized thiopurine therapy
Background: Thiopurines, including azathioprine and 6-mercaptopurine, are widely used in the treatment of inflammatory and autoimmune diseases, as well as hematological malignancies; however, their use is limited by the risk of severe myelosuppression. Pharmacogenetic variants in the TPMT and NUDT15 genes significantly affect drug tolerability, and their frequencies vary markedly across ethnic groups, making population-based studies of these markers in different regions of Russia particularly important. Aim: To assess interethnic variability in the frequencies of clinically relevant TPMT rs1142345 and NUDT15 rs116855232 polymorphisms in populations of the Volga-Ural region, North Caucasus, and the Lower Volga region. Methods: Data from 1687 healthy males from 27 populations and 15 ethnogeographic groups (Bashkirs, Tatars, Mordvins, Chuvash, Mari, Udmurts, Komi, Besermyans, Kalmyks, Balkars, Karachays, Circassians, Ingush, Chechens, and Moldovans), collected during field expeditions in 2000–2025, were retrospectively analyzed. Information on date and place of birth, family history of disease, ethnicity of parents and grandparents (maternal and paternal lines), and causes of death of closed relatives was collected by questionnaire. Individuals with mixed ancestry were excluded. Genomic DNA was extracted from venous blood; genotyping of TPMT rs1142345 and NUDT15 rs116855232 was performed by real-time polymerase chain reaction with TaqMan probes. Results: The minor allele rs1142345*C of TPMT (TPMT*3C) was rare or absent in most of the studied groups, with the highest frequencies observed in Chuvash (3.65%), Circassians (3.23%), and Mordvins (3.16%). The minor allele rs116855232*T of NUDT15 (NUDT15*3) was more frequent in Kalmyks (15.6%), Bashkirs from Perm Krai (14.77%), and Bashkirs of the Samara and Saratov Regions (14.63%), whereas it was absent in Moldovans and occurred at minimal frequencies in Mordvins (0.52%), Chechens (1.03%) and Ingush (1.61%). The most significant differences in NUDT15*3 allele frequency were observed between Kalmyks and Mordvins (15.60% vs 0.52%; p = 2.7 × 10-9, p_FDR = 9.3 × 10-7), Kalmyks and Chechens (15.60% vs 1.03%; p = 2.4 × 10-8, p_FDR = 3.8 × 10-6), and Kalmyks and Moldovans (15.60% vs 0.0%; p = 3.2 × 10-8, p_FDR = 3.8 × 10-6). Among the Bashkir subgroups, the greatest differences were found between Bashkirs from Perm Krai and Mordvins (14.77% vs 0.52%; p = 1.4 × 10-6, p_FDR = 1.3 × 10-4), between Bashkirs from Samara and Saratov Regions and Mordvins (14.63% vs 0.52%; p = 2.5 × 10-6, p_FDR = 1.8 × 10-4), and between Bashkirs from Perm Krai and Moldovans (14.77% vs 0.0%; p = 3.4 × 10-6, p_FDR = 2.0 × 10-4) and Chechens (14.77% vs 1.03%; p = 8.0 × 10-6, p_FDR = 3.5 × 10-4). Conclusion: The results confirm substantial ethnic heterogeneity in the distribution of pharmacogenetic markers of thiopurine toxicity. The minor allele rs116855232*T of NUDT15 was significantly more prevalent in the studied populations than the minor allele rs1142345*C of TPMT, and its frequencies in several groups were comparable to those in East Asian populations. This supports the utility of genotyping for personalizing azathioprine therapy in Russian regions.
- 1 February 2026
- Published by Pleiades Publishing Ltd in Russian Journal of Genetics
- Vol. 62 (2) , 217-225
A Novel Missense Variant in the GCH1 Gene Identified in Patients with Dopa-Responsive Dystonia
Mutations in the guanosine triphosphate cyclohydrolase-1 (GCH1) gene are the most common cause of hereditary dopa-responsive dystonia (DRD), designated as DYT5a (OMIM #128230). The most typical manifestations of this form of the disease include childhood manifestations in the form of focal dystonia (mainly in the foot), diurnal fluctuations, and sometimes a combination of dystonia with mild parkinsonism. The main feature of DYT5a is the good and sustained efficacy of treatment with a low dose of L‑Dopa. At the same time, the rarity of the disease itself and a significant variety of mutations and clinical heterogeneity, including atypical manifestations, do not allow establishing clear genotypic correlations, complicating its early diagnosis. In this regard, identification of pathogenic variants causing the development of DYT5a, studies of clinical and genetic features of various genetic variants of the disease and their prevalence in populations are relevant. In this report, we present information on a new missense variant in the GCH1 gene—c.710A>G (p.Asp237Gly) (NM_000161.3), identified as a result of whole-genome sequencing in a family with an autosomal dominant form of dystonia from the Republic of Bashkortostan. On the basis of bioinformatic analysis, this nucleotide variant is interpreted as having a damaging effect. In the heterozygous state, it was identified in two affected family members and in two close relatives without signs of dystonia. The clinical picture of the disease in both affected women from this family corresponds to the classical DYT5a. This variant was not detected in the control population samples of healthy individuals. No other pathogenic variants in genes known for dystonia were detected in patients from the examined family. On the basis of the totality of data, we assume that the missense variant c.710A>G (p.Asp237Gly) in the GCH1 gene is most likely the cause of the disease and can be further classified as “pathogenic” characterized by incomplete penetrance, which requires additional functional studies.
- 1 February 2026
- Published by Pleiades Publishing Ltd in Russian Journal of Genetics
- Vol. 62 (2) , 217-225
A Novel Missense Variant in the GCH1 Gene Identified in Patients with Dopa-Responsive Dystonia
Mutations in the guanosine triphosphate cyclohydrolase-1 (GCH1) gene are the most common cause of hereditary dopa-responsive dystonia (DRD), designated as DYT5a (OMIM #128230). The most typical manifestations of this form of the disease include childhood manifestations in the form of focal dystonia (mainly in the foot), diurnal fluctuations, and sometimes a combination of dystonia with mild parkinsonism. The main feature of DYT5a is the good and sustained efficacy of treatment with a low dose of L‑Dopa. At the same time, the rarity of the disease itself and a significant variety of mutations and clinical heterogeneity, including atypical manifestations, do not allow establishing clear genotypic correlations, complicating its early diagnosis. In this regard, identification of pathogenic variants causing the development of DYT5a, studies of clinical and genetic features of various genetic variants of the disease and their prevalence in populations are relevant. In this report, we present information on a new missense variant in the GCH1 gene—c.710A>G (p.Asp237Gly) (NM_000161.3), identified as a result of whole-genome sequencing in a family with an autosomal dominant form of dystonia from the Republic of Bashkortostan. On the basis of bioinformatic analysis, this nucleotide variant is interpreted as having a damaging effect. In the heterozygous state, it was identified in two affected family members and in two close relatives without signs of dystonia. The clinical picture of the disease in both affected women from this family corresponds to the classical DYT5a. This variant was not detected in the control population samples of healthy individuals. No other pathogenic variants in genes known for dystonia were detected in patients from the examined family. On the basis of the totality of data, we assume that the missense variant c.710A>G (p.Asp237Gly) in the GCH1 gene is most likely the cause of the disease and can be further classified as “pathogenic” characterized by incomplete penetrance, which requires additional functional studies.
- Open Access
- 26 December 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (1) , 103
Evaluation of Polygenic Risk Score for Prediction of Childhood Onset and Severity of Asthma
Asthma is a common complex disease with susceptibility defined through an interplay of genetic and environmental factors. Responsiveness to asthma treatment varies between individuals and is largely determined by genetic variability. The polygenic score (PGS) approach enables an individual risk of asthma and respective response to drug therapy. PGS models could help to predict the individual risk of asthma using 26 SNPs of drug pathway genes involved in the metabolism of glucocorticosteroids (GCS), and beta-2-agonists, antihistamines, and antileukotriene drugs associated with the response to asthma treatment within GWAS were built. For PGS, summary statistics from the Trans-National Asthma Genetic Consortium GWAS meta-analysis, and genotype data for 882 individuals with asthma/controls from the Volga-Ural region, were used. The study group was comprised of Russian, Tatar, Bashkir, and mixed ethnicity individuals with asthma (N = 378) aged 2–18 years. and individuals without features of atopic disease (N = 504) aged 4–67 years from the Volga-Ural region. The DNA samples for the study were collected from 2000 to 2021. The drug pathway genes’ PGS revealed a higher odds for childhood asthma risk (p = 2.41 × 10−12). The receiver operating characteristic (ROC) analysis showed an Area Under the Curve, AUC = 0.63. The AUC of average significance for moderate-to-severe and severe asthma was observed (p = 5.7 × 10−9, AUC = 0.64). Asthma drug response pathway gene variant PGS models may contribute to the development of modern approaches to optimise asthma diagnostics and treatment.
- 26 December 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (1) , 103
Open AccessEvaluation of Polygenic Risk Score for Prediction of Childhood Onset and Severity of Asthma
Asthma is a common complex disease with susceptibility defined through an interplay of genetic and environmental factors. Responsiveness to asthma treatment varies between individuals and is largely determined by genetic variability. The polygenic score (PGS) approach enables an individual risk of asthma and respective response to drug therapy. PGS models could help to predict the individual risk of asthma using 26 SNPs of drug pathway genes involved in the metabolism of glucocorticosteroids (GCS), and beta-2-agonists, antihistamines, and antileukotriene drugs associated with the response to asthma treatment within GWAS were built. For PGS, summary statistics from the Trans-National Asthma Genetic Consortium GWAS meta-analysis, and genotype data for 882 individuals with asthma/controls from the Volga-Ural region, were used. The study group was comprised of Russian, Tatar, Bashkir, and mixed ethnicity individuals with asthma (N = 378) aged 2–18 years. and individuals without features of atopic disease (N = 504) aged 4–67 years from the Volga-Ural region. The DNA samples for the study were collected from 2000 to 2021. The drug pathway genes’ PGS revealed a higher odds for childhood asthma risk (p = 2.41 × 10−12). The receiver operating characteristic (ROC) analysis showed an Area Under the Curve, AUC = 0.63. The AUC of average significance for moderate-to-severe and severe asthma was observed (p = 5.7 × 10−9, AUC = 0.64). Asthma drug response pathway gene variant PGS models may contribute to the development of modern approaches to optimise asthma diagnostics and treatment.
- 23 April 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (7) , 165-168
Amyotrophic lateral sclerosis associated with a new pathogenic variant of the ERBB4 gene
Amyotrophic lateral sclerosis (ALS) is a sporadic disease in most of the cases; in 10—15% of cases genetic forms are recorded. A genetic form of ALS associated with the mutation in the ERBB4 gene (ALS19) has been reported in 2013. A protein encoded by the ERBB4 is probably involved in ubiquitous component of the pathogenesis of ALS. We present a case of ALS associated with a new pathogenic variant of the ERBB4 gene, with early bulbar onset and slow progression of the disease within 10 years.
- 23 April 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (7) , 165-168
Amyotrophic lateral sclerosis associated with a new pathogenic variant of the ERBB4 gene
Amyotrophic lateral sclerosis (ALS) is a sporadic disease in most of the cases; in 10—15% of cases genetic forms are recorded. A genetic form of ALS associated with the mutation in the ERBB4 gene (ALS19) has been reported in 2013. A protein encoded by the ERBB4 is probably involved in ubiquitous component of the pathogenesis of ALS. We present a case of ALS associated with a new pathogenic variant of the ERBB4 gene, with early bulbar onset and slow progression of the disease within 10 years.
- Open Access
- 5 January 2024
- Published by Publishing House ABV Press in Neuromuscular Diseases
- Vol. 13 (4) , 74‑82
Hereditary spastic paraplegias
Hereditary spastic paraplegias represent a group of hereditary neurodegenerative disorders predominantly affecting corticospinal tracts which manifest with prominent spasticity and reduced power in the muscles of the lower limbs. According to clinical signs hereditary spastic paraplegias are divided into uncomplicated (classic) and complicated forms, according to the nature of inheritance – into autosomal dominant, autosomal recessive and X-linked. Mechanisms of the development of hereditary spastic paraplegias depend on the form and could be associated with misfolding of the proteins in endoplasmatic reticulum, mitochondrial dysfunction, changes in the cholesterol metabolism etc. Diagnosis is made after exclusion of other disorders of the central nervous system and could be confirmed by molecular genetic methods. Treatment of hereditary spastic paraplegias is symptomatic.
- 5 January 2024
- Published by Publishing House ABV Press in Neuromuscular Diseases
- Vol. 13 (4) , 74‑82
Open AccessHereditary spastic paraplegias
Hereditary spastic paraplegias represent a group of hereditary neurodegenerative disorders predominantly affecting corticospinal tracts which manifest with prominent spasticity and reduced power in the muscles of the lower limbs. According to clinical signs hereditary spastic paraplegias are divided into uncomplicated (classic) and complicated forms, according to the nature of inheritance – into autosomal dominant, autosomal recessive and X-linked. Mechanisms of the development of hereditary spastic paraplegias depend on the form and could be associated with misfolding of the proteins in endoplasmatic reticulum, mitochondrial dysfunction, changes in the cholesterol metabolism etc. Diagnosis is made after exclusion of other disorders of the central nervous system and could be confirmed by molecular genetic methods. Treatment of hereditary spastic paraplegias is symptomatic.
- Open Access
- 15 June 2023
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 45 (6) , 5145-5163
Study of The Molecular Nature of Congenital Cataracts in Patients from The Volga–Ural Region
Hereditary cataracts are characterized by significant clinical and genetic heterogeneity, which can pose challenges for early DNA diagnosis. To comprehensively address this problem, it is essential to investigate the epidemiology of the disease, perform population studies to determine the spectrum and frequencies of mutations in the responsible genes, and examine clinical and genetic correlations. Based on modern concepts, non-syndromic hereditary cataracts are predominantly caused by genetic disease forms associated with mutations in crystallin and connexin genes. Therefore, a comprehensive approach to studying hereditary cataracts is necessary for early diagnosis and improved treatment outcomes. The crystallin (CRYAA, CRYAB, CRYGC, CRYGD, and CRYBA1) and connexin (GJA8, GJA3) genes were analyzed in 45 unrelated families from the Volga–Ural Region (VUR) with hereditary congenital cataracts. Pathogenic and probably pathogenic nucleotide variants were identified in ten unrelated families, nine of which had cataracts in an autosomal dominant pattern of inheritance. Two previously undescribed likely pathogenic missense variants were identified in the CRYAA gene: c.253C > T (p.L85F) in one family and c.291C > G (p.H97Q) in two families. The known mutation c.272_274delGAG (p.G91del) was found in the CRYBA1 gene in one family, while no pathogenic variants were found in the CRYAB, CRYGC, or CRYGD genes in the examined patients. In the GJA8 gene, the known mutation c.68G > C (p.R23T) was found in two families, and previously undescribed variants were identified in two other families: a c.133_142del deletion (p.W45Sfs*72) and a missense variant, c.179G > A (p.G60D). In one patient with a recessive form of cataract, two compound-heterozygous variants were identified—a previously undescribed likely pathogenic missense variant, c.143A > G (p.E48G), and a known variant with uncertain pathogenetic significance, c.741T > G (p.I24M). Additionally, a previously undescribed deletion, c.del1126_1139 (p.D376Qfs*69), was identified in the GJA3 gene in one family. In all families where mutations were identified, cataracts were diagnosed either immediately after birth or during the first year of life. The clinical presentation of the cataracts varied depending on the type of lens opacity, resulting in various clinical forms. This information emphasizes the importance of early diagnosis and genetic testing for hereditary congenital cataracts to guide appropriate management and improve outcomes.
- 15 June 2023
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 45 (6) , 5145-5163
Open AccessStudy of The Molecular Nature of Congenital Cataracts in Patients from The Volga–Ural Region
Hereditary cataracts are characterized by significant clinical and genetic heterogeneity, which can pose challenges for early DNA diagnosis. To comprehensively address this problem, it is essential to investigate the epidemiology of the disease, perform population studies to determine the spectrum and frequencies of mutations in the responsible genes, and examine clinical and genetic correlations. Based on modern concepts, non-syndromic hereditary cataracts are predominantly caused by genetic disease forms associated with mutations in crystallin and connexin genes. Therefore, a comprehensive approach to studying hereditary cataracts is necessary for early diagnosis and improved treatment outcomes. The crystallin (CRYAA, CRYAB, CRYGC, CRYGD, and CRYBA1) and connexin (GJA8, GJA3) genes were analyzed in 45 unrelated families from the Volga–Ural Region (VUR) with hereditary congenital cataracts. Pathogenic and probably pathogenic nucleotide variants were identified in ten unrelated families, nine of which had cataracts in an autosomal dominant pattern of inheritance. Two previously undescribed likely pathogenic missense variants were identified in the CRYAA gene: c.253C > T (p.L85F) in one family and c.291C > G (p.H97Q) in two families. The known mutation c.272_274delGAG (p.G91del) was found in the CRYBA1 gene in one family, while no pathogenic variants were found in the CRYAB, CRYGC, or CRYGD genes in the examined patients. In the GJA8 gene, the known mutation c.68G > C (p.R23T) was found in two families, and previously undescribed variants were identified in two other families: a c.133_142del deletion (p.W45Sfs*72) and a missense variant, c.179G > A (p.G60D). In one patient with a recessive form of cataract, two compound-heterozygous variants were identified—a previously undescribed likely pathogenic missense variant, c.143A > G (p.E48G), and a known variant with uncertain pathogenetic significance, c.741T > G (p.I24M). Additionally, a previously undescribed deletion, c.del1126_1139 (p.D376Qfs*69), was identified in the GJA3 gene in one family. In all families where mutations were identified, cataracts were diagnosed either immediately after birth or during the first year of life. The clinical presentation of the cataracts varied depending on the type of lens opacity, resulting in various clinical forms. This information emphasizes the importance of early diagnosis and genetic testing for hereditary congenital cataracts to guide appropriate management and improve outcomes.
- 13 September 2022
- Published by Pleiades Publishing Ltd in Russian Journal of Genetics
- Vol. 58 (9) , 1145-1153
Analysis of ATL1 Gene Mutations and Clinical Features of the Disease Course in Patients with Hereditary Spastic Paraplegia
Hereditary spastic paraplegia (HSP) is a group of neurodegenerative disorders with a predominant lesion of the pyramidal tract. The autosomal dominant form of SPG3A, associated with mutations in the ATL1 gene, is one of the most common forms of HSP in European populations. Analysis of the ATL1 gene was performed in 63 unrelated families with HSP from the Republic of Bashkortostan. Two pathogenic variants were identified: one patient had a duplication of the entire third exon, and seven patients from three unrelated families had a missense mutation c.1246C>T (p.Arg416Cys). The frequency of SPG3A among unrelated patients in Bashkortostan was 6.3%. In one of the examined families, the origin of the c.1246C>T de novo mutation was established. The clinical symptoms of the disease in most cases correspond to uncomplicated HSP occurring in a mild form. Intrafamilial differences in clinical manifestations of the disease, including in identical twins, were revealed. The age of manifestation in the majority of examined patients ranged from 10 to 50 years.
- 13 September 2022
- Published by Pleiades Publishing Ltd in Russian Journal of Genetics
- Vol. 58 (9) , 1145-1153
Analysis of ATL1 Gene Mutations and Clinical Features of the Disease Course in Patients with Hereditary Spastic Paraplegia
Hereditary spastic paraplegia (HSP) is a group of neurodegenerative disorders with a predominant lesion of the pyramidal tract. The autosomal dominant form of SPG3A, associated with mutations in the ATL1 gene, is one of the most common forms of HSP in European populations. Analysis of the ATL1 gene was performed in 63 unrelated families with HSP from the Republic of Bashkortostan. Two pathogenic variants were identified: one patient had a duplication of the entire third exon, and seven patients from three unrelated families had a missense mutation c.1246C>T (p.Arg416Cys). The frequency of SPG3A among unrelated patients in Bashkortostan was 6.3%. In one of the examined families, the origin of the c.1246C>T de novo mutation was established. The clinical symptoms of the disease in most cases correspond to uncomplicated HSP occurring in a mild form. Intrafamilial differences in clinical manifestations of the disease, including in identical twins, were revealed. The age of manifestation in the majority of examined patients ranged from 10 to 50 years.
- 1 January 2021
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 4,p. 14-19
Association analysis of serotonin system gene polymorphisms (5-HTT, HTR1B, HTR2A, HTR2C, and TPH1) with the risk of Parkinson's disease in Tatars
Несмотря на длительную историю изучения взаимодействия дофамина и серотонина между собой, до сих пор нет точного определения роли серотонинергической передачи в модуляции активности дофаминергических нейронов [18]. Показано, что у пациентов с болезнью Паркинсона (БП) наблюдаются уменьшение общего количества серотони-нергических нейронов и телец Леви в них [12,19], снижение уровня серотонина и экспрессии транспортера серотонина [15]. В то же время, отмечено повышение уровня экспрессии рецепторов 5-HT2C [7]. Важным моментом стало наблюдение отсутствия корреляции потери транспортера с длительностью заболевания и инвалидностью [21]. Ранее нами были представлены результаты большого ассоциативного клинико-генетического исследования влияния генов дофаминергической системы на развитие БП в одной из наиболее многочисленных этнических групп населения Республики Башкортостан (РБ) - у этнических татар...
- 1 January 2021
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 4,p. 14-19
Association analysis of serotonin system gene polymorphisms (5-HTT, HTR1B, HTR2A, HTR2C, and TPH1) with the risk of Parkinson's disease in Tatars
Несмотря на длительную историю изучения взаимодействия дофамина и серотонина между собой, до сих пор нет точного определения роли серотонинергической передачи в модуляции активности дофаминергических нейронов [18]. Показано, что у пациентов с болезнью Паркинсона (БП) наблюдаются уменьшение общего количества серотони-нергических нейронов и телец Леви в них [12,19], снижение уровня серотонина и экспрессии транспортера серотонина [15]. В то же время, отмечено повышение уровня экспрессии рецепторов 5-HT2C [7]. Важным моментом стало наблюдение отсутствия корреляции потери транспортера с длительностью заболевания и инвалидностью [21]. Ранее нами были представлены результаты большого ассоциативного клинико-генетического исследования влияния генов дофаминергической системы на развитие БП в одной из наиболее многочисленных этнических групп населения Республики Башкортостан (РБ) - у этнических татар...